| Date |
Report No. |
Title |
| Date Sept. 14, 2011 |
Report No. GAO-11-936T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 10:00 a.m. EDT Wednesday, September 14, 2011 Testimony Before the Committee on Health, Education, Labor, and Pensions, U.S. Senate DRUG SAFETY FDA Faces Challenges Overseeing the Foreign Drug Manufacturing Supply Chain
Statement of Marcia Crosse Director, Health Care GAO-11-936T September 14, 2011 DRUG SAFETY
FD... |
| Date Sept. 30, 2010 |
Report No. GAO-10-961 |
Title
United States Government Accountability Office GAO
September 2010 Report to the Committee on Oversight and Government Reform, House of Representatives DRUG SAFETY FDA Has Conducted More Foreign Inspections and Begun to Improve Its Information on Foreign Establishments, but More Progress Is Needed GAO-10-961 September 2010 DRUG SAFETY
Accountability • Integrity • Reliability FDA Has Conducted M... |
| Date July 20, 2009 |
Report No. GAO-09-806 |
Title
United States Government Accountability Office GAO
July 2009 Report to the Ranking Member, Committee on Foreign Relations, U.S. Senate DRUG CONTROL U.S. Counternarcotics Cooperation with Venezuela Has Declined GAO-09-806 July 2009 DRUG CONTROL Highlights
Highlights of GAO-09-806, a report to the Ranking Member, Committee on Foreign Relations, U.S. Senate Accountability Integrity Reliability U.S. C... |
| Date March 20, 2009 |
Report No. GAO-09-63 |
Title
United States Government Accountability Office GAO
March 2009 Report to the Co-Chairman, Caucus on International Narcotics Control, U.S. Senate DRUG CONTROL Better Coordination with the Department of Homeland Security and an Updated Accountability Framework Can Further Enhance DEA’s Efforts to Meet Post-9/11 Responsibilities GAO-09-63 March 2009 DRUG CONTROL Highlights
Highlights of GAO-09-63, a... |
| Date Sept. 22, 2008 |
Report No. GAO-08-970 |
Title
United States Government Accountability Office GAO
September 2008 Report to Congressional Requesters DRUG SAFETY Better Data Management and More Inspections Are Needed to Strengthen FDA’s Foreign Drug Inspection Program GAO-08-970 September 2008 DRUG SAFETY Highlights
Highlights of GAO-08-970, a report to congressional requesters Accountability Integrity Reliability Better Data Management and Mo... |
